Kimball International stock (US48666K1097): what’s next after the takeover and delisting?
21.05.2026 - 23:38:37 | ad-hoc-news.deKimball International has largely disappeared from US stock screens after office furniture group HNI completed its acquisition and the company’s shares were subsequently delisted from Nasdaq in 2023, according to an announcement from HNI dated 06/01/2023 and Kimball International filings published the same day (HNI press release as of 06/01/2023). The transaction turned the former standalone furniture specialist into a business unit within HNI, but its brands and manufacturing footprint in the United States continue to operate in office, healthcare and hospitality furniture markets, according to company materials updated in 2023 (Kimball International website as of 09/2023).
As of: 21.05.2026
By the editorial team – specialized in equity coverage.
At a glance
- Name: KBAL
- Sector/industry: Office, hospitality and healthcare furniture
- Headquarters/country: Jasper, Indiana, United States
- Core markets: North American office, education, healthcare and hospitality interiors
- Key revenue drivers: Contract furniture for workplaces, health facilities and hotels
- Home exchange/listing venue: Previously Nasdaq (ticker KBAL) before acquisition by HNI
- Trading currency: Previously USD when listed
Kimball International: core business model
Kimball International has long focused on designing and manufacturing commercial furniture solutions, with a concentration on workplaces, hospitality venues and healthcare environments, according to the company’s corporate description updated in 2023 (Kimball International website as of 09/2023). Rather than operating as a mass-market furniture seller, it has historically targeted contract customers such as corporations, hospitals, universities and hotel chains that purchase furniture in larger volumes as part of broader interior projects.
The business model has combined in-house manufacturing with a network of dealers and sales representatives that work with architects, designers and facility managers to specify furniture lines for new buildings or renovations, according to product and distribution information published alongside the company’s 2022 annual report (Kimball International annual report 2022 as of 09/09/2022). Revenue is generated primarily through project-based sales rather than one-off retail transactions, which tends to link demand to corporate capital expenditure cycles and public-sector building budgets.
Over time, Kimball International developed several brands with differentiated positioning in the interiors market. The Kimball brand has historically focused on workplace solutions, National targeted value-oriented office and healthcare furniture, and other brands have addressed specific niches in hospitality and lounge seating, according to brand descriptions summarized in company materials released in 2022 (Kimball International brand overview as of 09/2022). These brands allowed the group to serve both premium and mid-market customers and to offer coordinated furniture lines across different spaces within the same building.
Manufacturing traditionally took place in company-owned facilities in Indiana and other US locations, complemented by some international sourcing, according to disclosures in the 2022 Form 10-K filed with the SEC on 08/19/2022 (SEC Form 10-K as of 08/19/2022). This gave Kimball International control over quality and lead times, a key requirement when fulfilling large, time-sensitive contracts for institutional customers.
Main revenue and product drivers for Kimball International
Before its acquisition, Kimball International’s revenue mix was heavily skewed toward the United States, with the company deriving the vast majority of its sales from North American customers in the fiscal year ended 06/30/2022, according to figures published with the 2022 annual report on 09/09/2022 (Kimball International annual report 2022 as of 09/09/2022). Within that geographic footprint, demand has been tied to corporate spending on office interiors, healthcare facility expansions and remodels, and hospitality investments in hotels and public spaces.
Workplace furniture – including desks, benching systems, seating, storage and collaborative tables – has historically been a major revenue driver, especially for projects involving large office floors or multi-site rollouts, as described in product category disclosures that accompanied the 2022 Form 10-K (SEC Form 10-K as of 08/19/2022). The rise of more flexible office layouts, including collaborative zones and touchdown spaces, has shaped product development in areas such as modular seating and adaptable workstations.
Healthcare furniture – such as patient room casegoods, recliners, exam tables and waiting area seating – has formed another important pillar. Kimball International has addressed this market with lines designed around durability, cleanability and infection control, which became particularly relevant during the pandemic period, according to healthcare product information referenced in company marketing materials updated in 2022 (Kimball International healthcare overview as of 10/2022). Projects in this segment depend on hospital construction cycles, clinic expansions and public funding dynamics.
The hospitality segment, encompassing hotel guest room furniture, lobby seating and public-area casegoods, has also contributed to revenue, though the proportion has varied over economic cycles. After the severe downturn in travel during the early stages of COVID-19, the company reported gradual recovery in hospitality orders in the fiscal year 2022, according to commentary in the 2022 annual report published on 09/09/2022 (Kimball International annual report 2022 as of 09/09/2022). Demand in this area tends to track hotel renovation cycles and broader travel trends.
On the cost side, input prices for materials such as steel, wood components and upholstery fabrics, as well as logistics and labor costs, have historically influenced Kimball International’s margins. In the fiscal year 2022, management highlighted inflationary pressures in materials and freight and described pricing actions and cost controls as key mitigants, according to management discussion and analysis in the 2022 Form 10-K filed on 08/19/2022 (SEC Form 10-K as of 08/19/2022). These dynamics remain relevant for the business as part of HNI’s consolidated operations.
Read more
Additional news and developments on the stock can be explored via the linked overview pages.
Conclusion
For US-focused investors, Kimball International now exists primarily as a legacy ticker and a set of brands residing inside HNI following the completion of the acquisition and delisting in 2023, as documented in the acquirer’s transaction announcement dated 06/01/2023 (HNI press release as of 06/01/2023). While the former standalone stock is no longer tradable on Nasdaq, the underlying furniture operations continue to be exposed to office, healthcare and hospitality spending cycles in the United States, which shape HNI’s consolidated performance. Any assessment now centers on how successfully HNI integrates the business, realises cost and revenue synergies and navigates evolving workplace and healthcare investment trends, rather than on Kimball International as an independent equity story.
Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.
So schätzen die Börsenprofis KBAL Aktien ein!
Für. Immer. Kostenlos.
